- Home
- PRQR vs RM Comparison
PRQR vs RM Comparison
Compare PRQR & RM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- RM
- Stock Information
- Founded
- PRQR 2012
- RM 1987
- Country
- PRQR Netherlands
- RM United States
- Employees
- PRQR N/A
- RM N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- RM Finance: Consumer Services
- Sector
- PRQR Health Care
- RM Finance
- Exchange
- PRQR Nasdaq
- RM Nasdaq
- Market Cap
- PRQR 309.5M
- RM 343.0M
- IPO Year
- PRQR 2014
- RM 2012
- Fundamental
- Price
- PRQR $1.37
- RM $31.35
- Analyst Decision
- PRQR Strong Buy
- RM Hold
- Analyst Count
- PRQR 6
- RM 3
- Target Price
- PRQR $8.50
- RM $31.50
- AVG Volume (30 Days)
- PRQR 723.0K
- RM 38.7K
- Earning Date
- PRQR 03-13-2025
- RM 04-30-2025
- Dividend Yield
- PRQR N/A
- RM 3.84%
- EPS Growth
- PRQR N/A
- RM 149.40
- EPS
- PRQR N/A
- RM 4.14
- Revenue
- PRQR $20,235,014.00
- RM $569,589,000.00
- Revenue This Year
- PRQR $39.44
- RM $14.45
- Revenue Next Year
- PRQR N/A
- RM $8.95
- P/E Ratio
- PRQR N/A
- RM $7.54
- Revenue Growth
- PRQR 196.41
- RM 6.62
- 52 Week Low
- PRQR $1.25
- RM $23.72
- 52 Week High
- PRQR $4.62
- RM $37.52
- Technical
- Relative Strength Index (RSI)
- PRQR 25.70
- RM 49.04
- Support Level
- PRQR $1.25
- RM $29.50
- Resistance Level
- PRQR $1.87
- RM $32.02
- Average True Range (ATR)
- PRQR 0.09
- RM 1.21
- MACD
- PRQR -0.02
- RM 0.19
- Stochastic Oscillator
- PRQR 21.43
- RM 75.83
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
About RM Regional Management Corp.
Regional Management Corp is a diversified consumer finance company that provides installment loan products to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders. It is engaged in consumer finance. The company has the core products which are small and large installment loans. The company also offers optional payment and collateral protection insurance. The company's principal source of revenue is interest and fee income on outstanding loans.